ALLMedicine™ Aortitis Center
Research & Reviews 288 results
https://emedicine.medscape.com/article/150490-overview:field_topic_overview_section:3:a5
Dec 7th, 2021 - Background Aortic regurgitation (AR) is the diastolic flow of blood from the aorta into the left ventricle (LV). Regurgitation is due to incompetence of the aortic valve or any disturbance of the valvular apparatus (eg, leaflets, annulus of the ao...
https://emedicine.medscape.com/article/150490-print
Dec 7th, 2021 - Background Aortic regurgitation (AR) is the diastolic flow of blood from the aorta into the left ventricle (LV). Regurgitation is due to incompetence of the aortic valve or any disturbance of the valvular apparatus (eg, leaflets, annulus of the ao...
https://doi.org/10.1177/17085381211058572
Vascular Perry J, Alslaim H et. al.
Dec 3rd, 2021 - This report aims to review the management and outcomes of Brucella-associated mycotic aortic aneurysms. This is a retrospective chart review at a tertiary-level healthcare system. IRB approval was waived per policy. We describe a case of Brucella ...
https://doi.org/10.1093/icvts/ivab313
Interactive Cardiovascular and Thoracic Surgery; Máximo J, Pissarra D et. al.
Nov 19th, 2021 - A 62-year-old female patient was admitted to hospital care due to an ischaemic stroke and fever of unknown origin, 6 months after a transfemoral aortic valve implantation for symptomatic aortic stenosis. Further study resulted in the diagnosis of ...
https://doi.org/10.1007/s10067-021-05978-z 10.1002/1529-0131(200004)43:4<901::AID-ANR23>3.0.CO;2-U 10.1097/HCO.0000000000000216 10.1016/j.carpath.2016.03.002 10.1016/j.carpath.2015.05.001 10.1002/art.41233 10.1016/j.carpath.2017.04.003 10.1002/art.40855 10.1016/j.autrev.2016.02.016 10.1016/j.jvs.2017.08.099 10.1016/j.avsg.2019.01.016 10.3899/jrheum.090081 10.1016/j.jtcvs.2014.08.003 10.1016/j.jvs.2005.10.010 10.1080/08941939.2017.1408718 10.1097/BOR.0000000000000762 10.1002/art.41774 10.1097/01.pas.0000213293.04026.ec 10.1002/art.40864 10.1007/s11926-020-00955-y 10.1016/j.berh.2020.101589 10.1002/art.33343
Clinical Rheumatology; Caterson HC, Li A et. al.
Nov 4th, 2021 - Aortitis is found in 2-12% of thoracic aortic aneurysm repair/replacement surgeries. Yet little is known about such patients' post-operative outcomes or the role of post-operative corticosteroids. The study was undertaken across three tertiary ref...
Guidelines 1 results
https://doi.org/10.1016/j.carpath.2015.05.001
Cardiovascular Pathology : the Official Journal of the So... Stone JR, Bruneval P et. al.
Jun 9th, 2015 - Inflammatory diseases of the aorta include routine atherosclerosis, aortitis, periaortitis, and atherosclerosis with excessive inflammatory responses, such as inflammatory atherosclerotic aneurysms. The nomenclature and histologic features of thes...
News 10 results
https://www.mdedge.com/vascularspecialistonline/article/202603/society-news/remain-connected-connect?channel=28399
Jun 17th, 2019 - How have you managed a possible infected aortitis, a severe focal stenosis or a fractured carotid stent? Give your input in discussions about these topics, and more, on your online community, SVSConnect. If you attended VAM last week, continue the.
https://www.mdedge.com/rheumatology/article/193094/lupus-connective-tissue-diseases/four-distinct-igg4-related-disease
Andrew D. Bowser
Jan 23rd, 2019 - IgG4-related disease can be grouped into four distinct clusters based on the distribution of organs involved, according to researchers who analyzed a large, multicenter cohort of patients with this heterogeneous, autoimmune-mediated condition. Dr.
http://www.fda.gov/drugs/drug-safety-and-availability/fda-notifies-amgen-misbranding-its-biological-product-neulasta-due-false-or-misleading-promotional
The Food and Drug Administration (FDA) has issued an untitled letter to Amgen Inc. for the misbranding of its biological product, Neulasta (pegfilgrastim) injection, for subcutaneous use, resulting from a false or misleading promotional communicat...
https://www.medpagetoday.com/rheumatology/generalrheumatology/50768
Apr 1st, 2015 - Action Points This consensus statement provides guidance for clinicians facing IgG4-related diseases, a relatively novel classification. Be aware that much of the evidence for managment of these related conditions are not informed by clinical tria...
https://www.medpagetoday.com/rheumatology/generalrheumatology/49505
Jan 13th, 2015 - Action Points Tocilizumab may offer a treatment option for refractory giant cell arteritis, providing symptomatic relief and reductions in markers of inflammation. Note that adverse events that led to discontinuation included severe neutropenia in...
